Open4.310 | Close4.060 |
Vol / Avg.1.844M / 1.289M | Mkt Cap800.361M |
Day Range3.985 - 4.399 | 52 Wk Range2.745 - 8.005 |
Sana Biotechnology Stock (NASDAQ: SANA) stock price, news, charts, stock research, profile.
Open4.310 | Close4.060 |
Vol / Avg.1.844M / 1.289M | Mkt Cap800.361M |
Day Range3.985 - 4.399 | 52 Wk Range2.745 - 8.005 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.450 | -0.410 | 0.0400 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.430 | -0.450 | -0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-10-12 | JMP Securities | Reni Benjamin | Maintains | Market OutperformMarket Outperform | Lowers | 9.00 | 8.00 |
2023-09-25 | JMP Securities | Reni Benjamin | Initiates Coverage On | Market Outperform | Announces | - | 9.00 |
2023-09-05 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 8.00 |
2023-08-14 | TD Cowen | Marc Frahm | Initiates Coverage On | Market Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SANA | Sana Biotechnology | -3.1% | 800.4M |
VALN | Valneva | 9.39% | 865.3M |
ZNTL | Zentalis Pharma | 6.03% | 796.1M |
AMAM | Ambrx Biopharma | -1.54% | 728.8M |
IMTX | Immatics | 2.79% | 748.4M |
You can purchase shares of Sana Biotechnology (NASDAQ: SANA) through any online brokerage.
Other companies in Sana Biotechnology’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharma (NASDAQ:ZNTL), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Tango Therapeutics (NASDAQ:TNGX).
The latest price target for Sana Biotechnology (NASDAQ: SANA) was reported by JMP Securities on Thursday, October 12, 2023. The analyst firm set a price target for 8.00 expecting SANA to rise to within 12 months (a possible 97.04% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Sana Biotechnology (NASDAQ: SANA) is $4.06 last updated November 30, 2023 at 9:20 PM UTC.
There is no dividend information for Sana Biotechnology.
Sana Biotechnology’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Sana Biotechnology.
Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.